Palo Alto, CA
Summary
This biotechnology company focuses on designing transformative medicines aimed at treating patients with genetic diseases and cancers that have identifiable genetic drivers. They employ a unique approach to drug development by integrating finance and science to expedite the process of turning scientific discoveries into viable patient solutions.